Society for Endocrinology - a world-leading authority on hormones

Semaglutide effective for adolescents with obesity

04 Nov 2022


Significant weight loss has been reported from the phase 3 trial of once-weekly injection of semaglutide in 12 to 18 year olds with obesity. The positive findings have been published in the New England Journal of Medicine.

Medscape